As the artificial intelligence boom continues to fuel an unprecedented appetite for high-performance memory chips, Micron Technology finds itself in...

All eyes are on Oracle as it prepares to release its quarterly earnings, presenting a stark contrast between immense promise...

Advanced Micro Devices (AMD) has navigated a challenging start to the year, weighed down by macroeconomic concerns and valuation questions...

The iShares MSCI World ETF has completed its first quarterly rebalancing for 2026, marking a notable departure from recent trends....

The specialized retail sector is approaching a significant test in March 2026. For Build-A-Bear Workshop, a company whose business model...

Axsome Therapeutics is entering a pivotal phase of commercial growth, with plans to significantly scale its operations and await a...

Axon Enterprise's latest quarterly figures have significantly surpassed market forecasts, highlighting the company's accelerating growth trajectory. The provider of security...

Within the fast-paced biotechnology landscape, Denali Therapeutics continues to command investor attention. The company's trajectory is being shaped by a...

A significant leadership change is imminent at uranium producer Energy Fuels. On April 15, 2026, Ross Bhappu, the company's current...

Investors in Deutsche Pfandbriefbank (PBB) faced a brutal reckoning as the German commercial property lender released its 2025 figures. The...